A study finds that the expanded CFvantage® panel, which detects up to 155 CFTR mutations, identified pathogenic CFTR mutations in a substantial proportion of samples that would have been missed by testing with the 23-mutation panel alone. Learn more about the October 8, 2015 poster presentation that took place at the American Society of Human Genetics Annual Meeting.
Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
WebinarsView All Webinars >
Steven Lamm, MD, a practicing internist and clinical professor at New York University School of Medicine, presents an educational webinar on the Assessment of Testosterone... Read more
Attendees learn about the poppy plant, opium composition and poppy seed opiates, poppy seeds as a dietary product, the fundamentals of opiates drug testing, ingesting... Read more
Karol E. Watson, MD, PhD, reviews the benefit of subfractionation and Ion Mobility to go beyond the traditional lipid panel, discusses the cardiovascular risk of... Read more
Expert InsightsView All Expert Insights >
Knowing the score: Identifying patients at high risk of liver fibrosis from Non-Alcoholic Fatty Liver Disease (NAFLD)
PublicationsView All Publications >
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Burger H, Weiser B, Gao W, Anastos K, Young M
AIDS Res Ther 2015;12:11
Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Brauer JA, Kazlouskaya Y, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, Geronemus RG
JAMA Dermatol 2015;151:278-284